Why is $TNYA moving today? · SEC 8-K archive

$TNYA SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $TNYA: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $TNYA filing catalyst

Why did $TNYA trigger an AI stock catalyst alert?

$TNYA triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: Tenaya Reports Q3 Loss of $0.08/Share, FDA Grants RMAT Designation for TN-401. Key points: - Net loss narrowed to $18.9M ($0.08/share) vs $20.3M ($0.12/share) year-over-year. - Received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for TN-401 gene therapy. - Management projects current cash runway extends into Q4 2027.

How did $TNYA stock react after the SEC filing?

After the SEC 8-K for $TNYA, observed market reaction: T0 price $0.37. Past moves do not guarantee future results.

Where can I get real-time $TNYA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $TNYA via Telegram and the VIP Web Terminal from €10/month.

$TNYA

$TNYA – Tenaya Reports Q3 Loss of $0.08/Share, FDA Grants RMAT Designation for TN-401

Tenaya Therapeutics, Inc.

2026-11-04 00:00:00 UTC · SEC 8-K · All $TNYA

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+1.5 / 10)

Net loss narrowed to $18.9M ($0.08/share) vs $20.3M ($0.12/share) year-over-year.
Received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for TN-401 gene therapy.
Management projects current cash runway extends into Q4 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →